{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:07:09Z","timestamp":1793329629284,"version":"4.5.0"},"reference-count":111,"publisher":"Elsevier BV","issue":"5","content-domain":{"domain":["bestpracticeobgyn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.bpobgyn.2014.04.006","type":"journal-article","created":{"date-parts":[[2014,4,30]],"date-time":"2014-04-30T19:18:13Z","timestamp":1398885493000},"page":"697-720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Imaging techniques for the evaluation of ovarian cancer"],"prefix":"10.1016","volume":"28","author":[{"given":"Daniela","family":"Fischerova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Burgetova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2014.04.006_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib2","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1056\/NEJM199311183292108","article-title":"Cancer of the ovary","volume":"329","author":"Cannistra","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/1098-2388(200007\/08)19:1<11::AID-SSU3>3.0.CO;2-3","article-title":"Current management of epithelial ovarian carcinoma: a review","volume":"19","author":"Marsden","year":"2000","journal-title":"Semin Surg Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib4","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/1097-0142(20001115)89:10<2068::AID-CNCR6>3.0.CO;2-Z","article-title":"Ovarian carcinoma diagnosis","volume":"89","author":"Goff","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib5","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0029-7844(01)01457-0","article-title":"Symptoms of ovarian cancer","volume":"98","author":"Olson","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib6","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/jnci\/djj019","article-title":"Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients","volume":"98","author":"Earle","year":"2006","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib7","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/cncr.21616","article-title":"Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma","volume":"106","author":"Engelen","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib8","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ctrv.2006.02.005","article-title":"Debulking surgery for ovarian epithelial cancer performed by a\u00a0gynaecological oncologist improved survival compared with less specialised surgeons","volume":"32","author":"Engelen","year":"2006","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib9","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ygyno.2012.04.012","article-title":"Centralisation of services for gynaecological cancers \u2013 a Cochrane systematic review","volume":"126","author":"Woo","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"Suppl. 1","key":"10.1016\/j.bpobgyn.2014.04.006_bib10","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1016\/j.ejso.2010.06.006","article-title":"Patterns of care in surgery for ovarian cancer in Europe","volume":"36","author":"Verleye","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib11","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1007\/s00330-010-1886-4","article-title":"ESUR guidelines: ovarian cancer staging and follow-up","volume":"20","author":"Forstner","year":"2010","journal-title":"Eur Radiol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib12","series-title":"World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs","first-page":"113","article-title":"Tumours of the ovary and peritoneum","author":"Lee","year":"2003"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0020-7292(00)90001-8","article-title":"FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology","volume":"70","author":"Benedet","year":"2000","journal-title":"Int J Gynaecol Obstet"},{"issue":"Suppl. 1","key":"10.1016\/j.bpobgyn.2014.04.006_bib14","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1016\/S0020-7292(06)60033-7","article-title":"Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer","volume":"95","author":"Heintz","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib15","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1158\/1055-9965.EPI-11-0422","article-title":"A\u00a0novel approach to predict the likelihood of specific ovarian tumor pathology based on serum CA-125: a multicenter observational study","volume":"20","author":"Van Calster","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000217748","article-title":"Use of serum tumor markers in the differential diagnosis between ovarian and colorectal adenocarcinomas","volume":"13","author":"Yedema","year":"1992","journal-title":"Tumour Biol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ygyno.2012.09.013","article-title":"Neoadjuvant chemotherapy in advanced ovarian cancer: on what do we agree and disagree?","volume":"128","author":"Vergote","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib18","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/IGC.0b013e31821b2568","article-title":"2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference","volume":"21","author":"Stuart","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib19","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib20","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"du Bois","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib21","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1525-1438.2007.01015.x","article-title":"Ultrasound-guided tru-cut biopsy in the management of advanced abdomino-pelvic tumors","volume":"18","author":"Fischerova","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib22","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/uog.8803","article-title":"Ultrasound-guided tru-cut biopsy of abdominal and pelvic tumors in gynecology","volume":"36","author":"Zikan","year":"2010","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib23","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/AOG.0b013e31822a6d56","article-title":"Thirty-day mortality after primary cytoreductive surgery for advanced ovarian cancer in the elderly","volume":"118","author":"Thrall","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ygyno.2010.09.010","article-title":"Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment","volume":"120","author":"Aletti","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib25","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ygyno.2004.11.031","article-title":"Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: a pilot study","volume":"96","author":"Fagotti","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib26","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/sj.bjc.6605292","article-title":"Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial","volume":"101","author":"Ferrandina","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/uog.10100","article-title":"Ultrasound evaluation of intra-abdominal sites of disease to predict likelihood\u00a0of suboptimal cytoreduction in advanced ovarian cancer: a prospective study","volume":"39","author":"Testa","year":"2012","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ygyno.2004.06.054","article-title":"Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer","volume":"96","author":"Qayyum","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib29","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1148\/radiology.197.3.7480729","article-title":"Ovarian cancer: staging with CT and MR imaging","volume":"197","author":"Forstner","year":"1995","journal-title":"Radiology"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib30","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ygyno.2008.10.010","article-title":"A\u00a0contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma","volume":"112","author":"Chi","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ygyno.2007.11.002","article-title":"Prediction of suboptimal primary cytoreduction in primary ovarian cancer with\u00a0combined positron emission tomography\/computed tomography\u2013a prospective study","volume":"108","author":"Risum","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib32","doi-asserted-by":"crossref","first-page":"642e641","DOI":"10.1016\/j.ajog.2008.06.052","article-title":"Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma","volume":"199","author":"Fagotti","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib33","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.ejso.2009.03.002","article-title":"A\u00a0multicenter validation of computerized tomography models as predictors of non- optimal primary cytoreduction of advanced epithelial ovarian cancer","volume":"35","author":"Gemer","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib34","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1200\/JCO.2006.07.7800","article-title":"Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer","volume":"25","author":"Axtell","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib35","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ygyno.2008.09.036","article-title":"Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: a systematic review","volume":"112","author":"du Bois","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1525-1438.2007.00826.x","article-title":"Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature","volume":"17","author":"Gadducci","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib37","series-title":"The NCCN guidelines","article-title":"Ovarian cancer","author":"Network NCC","year":"2013"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib38","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(10)61268-8","article-title":"Early versus delayed treatment of relapsed ovarian cancer (MRC OV05\/EORTC 55955): a randomised trial","volume":"376","author":"Rustin","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib39","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/01.cco.0000174166.06734.c7","article-title":"The role of surgery in ovarian cancer with special emphasis on cytoreductive surgery for recurrence","volume":"17","author":"Harter","year":"2005","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.critrevonc.2008.12.008","article-title":"Surveillance of patients after initial treatment of ovarian cancer","volume":"71","author":"Gadducci","year":"2009","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib41","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/IGC.0b013e3182261f15","article-title":"ESGO statement on the role of CA-125 measurement in follow-up of epithelial ovarian cancer","volume":"22","author":"van der Zee","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib42","first-page":"7","article-title":"Positron emission tomography in ovarian cancer: 18F-deoxy-glucose and 16alpha-18F-fluoro-17beta-estradiol PET","volume":"2","author":"Yoshida","year":"2009","journal-title":"J\u00a0Ovarian Res"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib43","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00404-013-3081-8","article-title":"The special role of ultrasound for screening, staging and surveillance of\u00a0malignant ovarian tumors: distinction from other methods of diagnostic imaging","volume":"289","author":"Manegold-Brauer","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib44","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1148\/radiol.12120315","article-title":"The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologist needs to know","volume":"266","author":"Sala","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib45","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00330-013-3083-8","article-title":"Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET\/CT","volume":"24","author":"Michielsen","year":"2014","journal-title":"Eur Radiol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib46","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/uog.10054","article-title":"Ultrasound scanning of the pelvis and abdomen for staging of gynecological tumors: a review","volume":"38","author":"Fischerova","year":"2011","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib47","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.ygyno.2005.07.116","article-title":"The role of sonographic examination in the follow-up of gynecological neoplasms","volume":"99","author":"Testa","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib48","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib49","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/uog.7309","article-title":"Dynamic and interactive gynecological ultrasound examination","volume":"34","author":"Testa","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib50","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/uog.7464","article-title":"Intravenous contrast ultrasound examination using contrast-tuned imaging (CnTI) and the contrast medium SonoVue for discrimination between benign and malignant adnexal masses with solid components","volume":"34","author":"Testa","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib51","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1046\/j.1469-0705.2000.00287.x","article-title":"Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group","volume":"16","author":"Timmerman","year":"2000","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib52","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/MNM.0b013e3281afa256","article-title":"Diagnostic accuracy of 18F-FDG PET\/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology","volume":"28","author":"Castellucci","year":"2007","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib53","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ygyno.2009.10.059","article-title":"Diagnosis and staging of primary ovarian cancer: correlation between PET\/CT, Doppler US, and CT or MRI","volume":"116","author":"Nam","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib54","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ygyno.2009.12.008","article-title":"Does the use of diagnostic PET\/CT cause stage migration in patients with primary advanced ovarian cancer?","volume":"116","author":"Risum","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib55","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ygyno.2012.04.023","article-title":"FDG PET\/CT in staging of advanced epithelial ovarian cancer: frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread","volume":"126","author":"Hynninen","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib56","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1046\/j.1469-0705.2002.00693.x","article-title":"Detection of central pelvic recurrent disease with transvaginal color Doppler ultrasound in women treated for gynecological malignancy","volume":"19","author":"Testa","year":"2002","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib57","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/uog.2587","article-title":"Transvaginal sonographic features of peritoneal carcinomatosis","volume":"26","author":"Savelli","year":"2005","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib58","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jacr.2013.07.017","article-title":"ACR appropriateness criteria staging and follow-up of ovarian cancer","volume":"10","author":"Mitchell","year":"2013","journal-title":"J\u00a0Am Coll Radiol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib59","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s00330-008-1121-8","article-title":"Image-guided biopsy in patients with suspected ovarian carcinoma: a safe and effective technique?","volume":"19","author":"Griffin","year":"2009","journal-title":"Eur Radiol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib60","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1471-0528.2006.01176.x","article-title":"Women with peritoneal carcinomatosis of unknown origin: efficacy of image-guided biopsy to determine site-specific diagnosis","volume":"114","author":"Hewitt","year":"2007","journal-title":"BJOG"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib61","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2214\/AJR.08.1283","article-title":"Predictive value of percutaneous imaging-guided biopsy of peritoneal and omental masses: results in 111 patients","volume":"192","author":"Souza","year":"2009","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib62","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00004424-198601000-00005","article-title":"Computed tomography in advanced ovarian cancer. Inter- and intraobserver reliability","volume":"21","author":"Warde","year":"1986","journal-title":"Invest Radiol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib63","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1148\/radiology.212.2.r99au19401","article-title":"Ovarian cancer: comparison of observer performance for four methods of interpreting CT scans","volume":"212","author":"Fultz","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib64","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejrad.2010.11.039","article-title":"Ovarian cancer management: the role of imaging and diagnostic challenges","volume":"78","author":"Bharwani","year":"2011","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib65","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00066-011-4002-z","article-title":"Imaging of female pelvic malignancies regarding MRI, CT, and PET\/CT: Part 2","volume":"187","author":"Alt","year":"2011","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib66","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nrclinonc.2010.47","article-title":"Imaging ovarian cancer and peritoneal metastases\u2013current and emerging techniques","volume":"7","author":"Kyriazi","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib67","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1148\/radiol.2232011081","article-title":"Peritoneal metastases: detection with spiral CT in patients with ovarian cancer","volume":"223","author":"Coakley","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib68","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1148\/radiology.215.3.r00jn25761","article-title":"Staging of advanced ovarian cancer: comparison of imaging modalities: report from the Radiological Diagnostic Oncology Group","volume":"215","author":"Tempany","year":"2000","journal-title":"Radiology"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib69","first-page":"1509","article-title":"Current concepts in lymph node imaging","volume":"45","author":"Torabi","year":"2004","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib70","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1007\/s00259-008-0890-2","article-title":"Diagnostic accuracy of integrated FDG-PET\/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT","volume":"35","author":"Kitajima","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib71","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.ygyno.2013.08.020","article-title":"PET\/CT in the staging of patients with a pelvic mass suspicious for ovarian cancer","volume":"131","author":"Dauwen","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib72","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1007\/s00330-013-2837-7","article-title":"Diffusion-weighted magnetic resonance imaging evaluation of intra-abdominal sites of implants to predict likelihood of suboptimal cytoreductive surgery in patients with ovarian carcinoma","volume":"23","author":"Espada","year":"2013","journal-title":"Eur Radiol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib73","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1102\/1470-7330.2006.0022","article-title":"Image guided biopsy in the management of cancer of the ovary","volume":"6","author":"Spencer","year":"2006","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib74","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/jmri.20864","article-title":"Diffusion-weighted MRI (DWI) in the oncology patient: value of breathhold DWI compared to unenhanced and gadolinium-enhanced MRI","volume":"25","author":"Low","year":"2007","journal-title":"J\u00a0Magn Reson Imaging"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib75","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2214\/AJR.08.1753","article-title":"Diffusion-weighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathologic findings\u2013a feasibility study","volume":"193","author":"Low","year":"2009","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib76","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1148\/rg.305105073","article-title":"Diffusion-weighted imaging of peritoneal disease for noninvasive staging of advanced ovarian cancer","volume":"30","author":"Kyriazi","year":"2010","journal-title":"Radiographics"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib77","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2214\/AJR.12.8932","article-title":"New MR techniques in gynecologic cancer","volume":"200","author":"Wakefield","year":"2013","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib78","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2214\/AJR.10.4687","article-title":"Diagnosis of peritoneal dissemination: comparison of 18F-FDG PET\/CT, diffusion-weighted MRI, and contrast-enhanced MDCT","volume":"196","author":"Satoh","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib79","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1148\/rg.241035178","article-title":"From the archives of the AFIP: radiologic staging of ovarian carcinoma with pathologic correlation","volume":"24","author":"Woodward","year":"2004","journal-title":"Radiographics"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib80","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1148\/radiology.204.2.9240546","article-title":"Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT","volume":"204","author":"Low","year":"1997","journal-title":"Radiology"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib81","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00330-002-1712-8","article-title":"Prospective evaluation of contrast-enhanced MRI in the depiction of peritoneal spread in primary or recurrent ovarian cancer","volume":"13","author":"Ricke","year":"2003","journal-title":"Eur Radiol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib82","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1245\/s10434-012-2236-3","article-title":"Combined diffusion-weighted and gadolinium-enhanced MRI can accurately predict the peritoneal cancer index preoperatively in patients being considered for cytoreductive surgical procedures","volume":"19","author":"Low","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib83","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s00330-012-2397-2","article-title":"Comparison of FDG-PET\/CT and MR with diffusion-weighted imaging for assessing peritoneal carcinomatosis from gastrointestinal malignancy","volume":"22","author":"Soussan","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib84","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1200\/JCO.2005.07.166","article-title":"Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer","volume":"23","author":"Rockall","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib85","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1148\/radiol.2353040447","article-title":"Treated ovarian cancer: MR imaging, laparotomy reassessment, and serum CA-125 values compared with clinical outcome at 1 year","volume":"235","author":"Low","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib86","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1148\/radiol.11110577","article-title":"Metastatic ovarian and primary peritoneal cancer: assessing chemotherapy response with diffusion-weighted MR imaging: value of histogram analysis of apparent diffusion coefficients","volume":"261","author":"Kyriazi","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib87","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ygyno.2006.11.022","article-title":"The diagnostic value of PET\/CT for primary ovarian cancer\u2013a prospective study","volume":"105","author":"Risum","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib88","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ygyno.2013.08.023","article-title":"A\u00a0prospective comparison of integrated FDG-PET\/contrast-enhanced CT and contrast-enhanced CT for pretreatment imaging of advanced epithelial ovarian cancer","volume":"131","author":"Hynninen","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib89","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ygyno.2006.10.060","article-title":"Clinical use of combined positron emission tomography and computed tomography (FDG-PET\/CT) in recurrent ovarian cancer","volume":"105","author":"Thrall","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib90","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s00261-007-9218-0","article-title":"PET-CT vs. CT alone in ovarian cancer recurrence","volume":"33","author":"Sebastian","year":"2008","journal-title":"Abdom Imaging"},{"issue":"Suppl. 2","key":"10.1016\/j.bpobgyn.2014.04.006_bib91","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1111\/IGC.0b013e3181bf8143","article-title":"Optimal management of recurrent ovarian cancer","volume":"19","author":"Markman","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib92","doi-asserted-by":"crossref","first-page":"7445","DOI":"10.1200\/JCO.2005.06.965","article-title":"Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer","volume":"23","author":"Avril","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib93","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/ijc.20057","article-title":"Expression of GLUT-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]-fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of the ovary","volume":"109","author":"Kurokawa","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib94","first-page":"930","article-title":"GLUT1 expression in tissue and (18)F-FDG uptake","volume":"45","author":"Avril","year":"2004","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib95","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijgo.2008.02.019","article-title":"Preoperative evaluation of pelvic masses with combined 18F-fluorodeoxyglucose positron emission tomography and computed tomography","volume":"102","author":"Yamamoto","year":"2008","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib96","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1016\/j.ejrad.2010.07.013","article-title":"FDG-PET\/CT in advanced ovarian cancer staging: value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy","volume":"80","author":"De Iaco","year":"2011","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib97","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/00004728-200407000-00011","article-title":"Evaluation of positron emission tomography with tracer 18-fluorodeoxyglucose in addition to magnetic resonance imaging in the diagnosis of ovarian cancer in selected women after ultrasonography","volume":"28","author":"Kawahara","year":"2004","journal-title":"J\u00a0Comput Assist Tomogr"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib98","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ygyno.2012.03.048","article-title":"Preoperative identification of a suspicious adnexal mass: a systematic review and meta-analysis","volume":"126","author":"Dodge","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib99","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2214\/ajr.182.1.1820227","article-title":"Incremental benefits of FDG positron emission tomography over CT alone for the preoperative staging of ovarian cancer","volume":"182","author":"Yoshida","year":"2004","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib100","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.ejrad.2011.01.112","article-title":"Computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography\/computer tomography for detection of metastatic lymph nodes in patients with ovarian cancer: a meta-analysis","volume":"81","author":"Yuan","year":"2012","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib101","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1006\/gyno.2000.5910","article-title":"Expression of GLUT-1 glucose transporter in borderline and malignant epithelial tumors of the ovary","volume":"79","author":"Cantuaria","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib102","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/IGC.0b013e31828a183c","article-title":"Accuracy of positron emission tomography\/computed tomography in the diagnosis and restaging for recurrent ovarian cancer: a meta-analysis","volume":"23","author":"Limei","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib103","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1157\/13073787","article-title":"Meta-analysis of the diagnostic efficacy of FDG-PET in patients with suspected ovarian cancer recurrence [in Spanish]","volume":"24","author":"Ruiz-Hernandez","year":"2005","journal-title":"Rev Esp Med Nucl"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib104","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1016\/j.ejrad.2012.03.020","article-title":"Low-dose non-enhanced CT versus full-dose contrast-enhanced CT in integrated PET\/CT scans for diagnosing ovarian cancer recurrence","volume":"81","author":"Kitajima","year":"2012","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib105","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejrad.2008.02.019","article-title":"CA 125, PET alone, PET-CT, CT and MRI in diagnosing recurrent ovarian carcinoma: a systematic review and meta-analysis","volume":"71","author":"Gu","year":"2009","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib106","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0090-8258(03)00336-6","article-title":"Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET\/CT","volume":"90","author":"Bristow","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib107","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1007\/s00259-007-0366-9","article-title":"Diagnostic accuracy of FDG PET in the follow-up of platinum-sensitive epithelial ovarian carcinoma","volume":"34","author":"Garcia-Velloso","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib108","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/IGC.0b013e3181a3cc94","article-title":"Influence of 2-(18F) fluoro-2-deoxy-D-glucose positron emission tomography\/computed tomography on recurrent ovarian cancer diagnosis and on selection of patients for secondary cytoreductive surgery","volume":"19","author":"Risum","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib109","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ygyno.2006.03.004","article-title":"The impact of PET\/CT in the management of recurrent ovarian cancer","volume":"103","author":"Simcock","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib110","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ygyno.2008.08.027","article-title":"The impact of PET-CT in suspected recurrent ovarian cancer: a prospective multi-centre study as part of the Australian PET Data Collection Project","volume":"112","author":"Fulham","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.006_bib111","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2214\/AJR.09.3522","article-title":"MRI, CT, and PET\/CT for ovarian cancer detection and adnexal lesion characterization","volume":"194","author":"Iyer","year":"2010","journal-title":"AJR Am J Roentgenol"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693414000637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693414000637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T17:21:20Z","timestamp":1597771280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693414000637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":111,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1521693414000637"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2014.04.006","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imaging techniques for the evaluation of ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2014.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}